T. Jacks
Molecular Biology · 2000–2023
A researcher in the Science corpus: 33 papers; trusts 6 researchers and is trusted by 21 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 386 citations into it; #2,407 of 17,773 by trust here, #215 by citations
- Cancer Research — 174 citations into it; #266 of 1,780 by trust here, #52 by citations
- Oncology — 119 citations into it; #696 of 1,698 by trust here, #128 by citations
- Hematology — 14 citations into it
Whom T. Jacks trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts T. Jacks overall
Papers from T. Jacks's perspective
Ordered by how strongly the researchers T. Jacks trusts endorse each paper. Same corpus, a different order for every researcher.
- Prediction of mammalian microRNA targets. (Cell)
- Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival (Cancer Research)
- Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. (Proceedings of the National Academy of Sciences of the United States of America)
- Impaired microRNA processing enhances cellular transformation and tumorigenesis (Nature Genetics)
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. (Cancer Cell)
- Extensive post-transcriptional regulation of microRNAs and its implications for cancer. (Genes & Development)
- The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. (Genes & Development)
- Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster (Nature Genetics)
- High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphoma (Genes, Chromosomes and Cancer)
- Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. (Cell)
Their papers
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals (2009) — 4,137 citations
- MicroRNA expression profiles classify human cancers (2005) — 9,882 citations
- Impaired microRNA processing enhances cellular transformation and tumorigenesis (2007) — 1,550 citations
- A large intergenic non-coding RNA induced by p53 mediates global gene repression in the p53 response (2010) — 2,069 citations
- Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) — 838 citations
- Somatic activation of the K-ras oncogene causes early onset lung cancer in mice (2001) — 1,217 citations
- Restoration of p53 function leads to tumour regression in vivo (2007) — 1,925 citations
- Cre-lox-regulated conditional RNA interference from transgenes. (2004) — 671 citations
- Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype (2014) — 943 citations
- Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. (2001) — 2,034 citations
- MicroRNAs and cancer: short RNAs go a long way. (2009) — 944 citations
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (2009) — 3,376 citations
- Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. (2004) — 850 citations
- Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. (2004) — 1,348 citations
- KRAS and YAP1 converge to regulate EMT and tumor survival (2014) — 758 citations
- CRISPR-mediated direct mutation of cancer genes in the mouse liver (2014) — 743 citations
- Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. (2000) — 649 citations
- Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. (2008) — 1,699 citations
- Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer (2016) — 676 citations
- Role for the p53 homologue p73 in E2F-1-induced apoptosis (2000) — 694 citations